LUCENTIS®
Indications
Lucentis is indicated in adults for:
- The treatment of neovascular (wet) age-related macular degeneration (AMD)
- The treatment of visual impairment due to diabetic macular edema (DME)
- The treatment of proliferative diabetic retinopathy (PDR)
- The treatment of visual impairment due to macular edema secondary to retinal vein occlusion (branch RVO or central RVO)
- The treatment of visual impairment due to choroidal neovascularization (CNV)
LUCENTIS®
AMD - Age-related Macular Degeneration
DME - Diabetic Macular Edema
CNV - Choroidal Neovascularization
PDR - Proliferative Diabetic Retinopathy
RVO - Retinal Vein Occlusion
Rate this content:
No votes yet
SG2308167841